NuVasive® VersaTie System
Bone Fixation Cerclage, Sublaminar. 510(k) K161265, from Nu Vasive, Incorporated (San Diego, CA). Product code OWI, class 2.
As of Nov 20, 2026, K161265 is an FDA 510(k) held by Nu Vasive, Incorporated, substantially equivalent on Jul 15, 2016 after 71 days, with no recalls tied to it in FDA's recall database.
- Review time: 71 days
- Recalls: 0
- Cited as a predicate by: 1 device
The NuVasive® VersaTie System is a temporary implant for use in orthopedic surgery. The System is intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. The indications for use include the following applications: 1. Spinal trauma surgery, used in sublaminar or facet wiring techniques; 2.
- Universal Clamp Spinal Fixation SystemK142053 · Zimmer Spine, Inc. · Oct 29, 2014
- JAZZ SystemK151740 · Implanet, S.A. · Aug 27, 2015
- NuVasive Reline SystemK143684 · Nu Vasive, Incorporated · Apr 23, 2015
- NuVasive® VersaTie™ SystemK173117 · Nuvasive, Inc. · Dec 7, 2017
- LigaPASS™ SystemK261374 · Medicrea International S.A.S · May 27, 2026
- Invictus Bands SystemK253615 · Alphatec Spine, Inc. · Mar 25, 2026
- OLYMPIC Deformity Band SystemK222097 · Astura Medical · May 4, 2023
- HILINE™ Fixation SystemK230565 · Globus Medical, Inc. · Apr 20, 2023
- LigaPASS™ 2.0 Ligament Augmentation SystemK213659 · Medicrea International SA · May 24, 2022
- LigaPASS® Spinal System, CD Horizon™ Spinal SystemK211057 · Medtronic, Inc. · May 27, 2021
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- May 5, 2016
- Review panel
- Orthopedic
- Regulation
- 21 CFR 888.3010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files